- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02485808
Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study
Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Phenotyping Study Protocol
Study Overview
Status
Conditions
Detailed Description
The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) was established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to advance our understanding of lower urinary tract dysfunction (LUTD) in women and men. LUTD is a term intended to be comprehensive and to challenge current paradigms about how symptomatic pelvic disorders are defined as 'diseases.' Lower urinary tract symptoms (LUTS) are likely caused and exacerbated by a variety of factors and thus do not represent the manifestation of a single disease. Clinical management of LUTD, including treatment outcomes, remains suboptimal since the biological and psychosocial factors that initiate, exacerbate, and modify this group of symptoms remain largely unknown. As an initial effort to better characterize the biological and psychosocial factors that initiate, exacerbate, and modify LUTS, the LURN investigators will establish a prospective Observational Cohort Study of men and women with LUTS presenting for the first time to LURN physicians.
Information to be obtained from study participants initially (at time of enrollment) includes a standardized clinical examination, medical history, select testing of the lower urinary tract, and participants' self-report of LUTS, pelvic floor symptoms including sexual function and bowel symptoms, depression, anxiety, sleep patterns, stress, metabolic risk factors, and health-related quality of life. We will also collect serum, urine, saliva, and perineal swabs from men and vaginal swabs from women for storage at the NIDDK Sample Repository for future study by the LURN investigators and the broader research community. This information will be used to construct subgroups of patients who have similar symptoms, clinical presentations, comorbidities, pelvic floor dysfunctions, and psychological profiles. These patient characteristics and behaviors likely affect the evaluation, diagnosis, and/or treatment of LUTS. Additional information will be collected 3 months and 12 months after enrollment or 3 and 12 months after surgery for patients receiving surgical treatment, and will include an interval clinical history, participants' self-report of LUTS, pelvic floor symptoms including sexual function and bowel symptoms, depression, anxiety, and health-related quality of life. We will also collect biological samples at 3 and 12 months after enrollment.
The LURN Neuroimaging and Sensory Testing component of the study will investigate abnormal sensation of the lower urinary tract at the level of the organism. Subjects and controls will have a one-time visit soon after their baseline visit, where they will undergo an fMRI scan of their brain and multimodal quantitative sensory testing assessing perceptual responses to physical stimuli (pain and sound).
The information to be collected from the prospective Observational Cohort Study will be limited and not sufficient to fully understand the pathophysiology and biology of LUTS. Therefore, the Observational Cohort Study will serve as the basis for further LURN studies. The long-term goal of the LURN is to better characterize patients with LUTD in order to advance future research on the pathophysiology of these
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University
-
-
North Carolina
-
Durham, North Carolina, United States, 27715
- Duke University
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Men and women presenting for new patient visits for evaluation or treatment of LUTS to one of the LURN physicians.
- Age ≥ 18 years.
- The presence of any of the symptoms reported in Table 1, based on responses to the LUTS Tool with a one month recall period.
- The ability to give informed consent and complete self-reported questionnaires electronically.
Table 1: LUTS Appropriate for Study Inclusion
- Daytime frequency
- Nocturia
- Urgency
- Incontinence/leakage (various types)
- Poor or absent sensation of bladder filling
- Slow/weak stream
- Splitting or spraying
- Intermittent stream/Double voiding
- Hesitancy
- Straining
- Dribbling at the end of flow
- Paruesis (shy bladder syndrome)
- Poor or absent sensation of urethra during void
- Feeling of incomplete emptying
- Post-micturition dribble (delayed)
- Abnormal bladder or urethral sensations
Exclusion Criteria:
- Gross hematuria.
- Significant neurologic disease or injury, including but not limited to: cerebral vascular accident with residual defect, Alzheimer's dementia, Parkinson's disease, traumatic brain injury, spinal cord injury, complicated spinal surgery, multiple sclerosis.
- Primary complaint is pelvic pain.
- Diagnosis of interstitial cystitis, chronic prostatitis, or chronic orchialgia.
- Pelvic or endoscopic GU surgery within the preceding 6 months (not including diagnostic cystoscopy).
- Current sexually transmitted infection. (deferral; subject can enroll after negative culture)
- Ongoing symptomatic urethral stricture.
- History of lower urinary tract or pelvic malignancy.
- Current chemotherapy or other cancer therapy.
- Pelvic device or implant complication (e.g., sling or mesh complications).
- Current functioning neurostimulator.
- Botox injection to the bladder or pelvic structures within the preceding 12 months.
- In men, prostate biopsy in the previous 3 months.
- In women, pregnancy.
- History of cystitis caused by tuberculosis, radiation therapy, or Cytoxan/cyclophosphamide therapy.
- Augmentation cystoplasty or cystectomy.
- Presence of urinary tract fistula.
- Current major psychiatric disorder or other psychiatric or medical issues that would interfere with study participation (e.g., dementia, psychosis, etc.).
- Inability to relay valid information, actively participate in the study, or provide informed consent (includes uncontrolled psychiatric disease).
- Difficulty reading or communicating in English.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Surgical
Men and women presenting for clinical care for whom surgical treatment of their lower urinary symptoms is planned. There will be no interventions, as this is an observational cohort. |
For surgical patients, follow-up assessments will occur 3 and 12 months after the surgery.
For medical patients, follow-up assessments will occur 3 and 12 months after the baseline assessment.
|
Medical
Men and women presenting for clinical care for whom medical treatment of their lower urinary symptoms is planned. There will be no interventions, as this is an observational cohort. |
For surgical patients, follow-up assessments will occur 3 and 12 months after the surgery.
For medical patients, follow-up assessments will occur 3 and 12 months after the baseline assessment.
|
Controls
Men and women who are not experiencing lower urinary tract symptoms. This group will undergo MRI, pain and auditory sensitivity testing. |
One time MRI scanning session examining brain structure and function in a resting state and after water consumption.
Other Names:
Pressure pain thresholds will be assess using computer-controlled pressures delivered by a device called the Multimodal Automated Sensory Testing System (MAST) device on to the subjects thumbnail bed.
Other Names:
Subjects' sensitivity to sound will be evaluated using a series of sounds delivered by a standard audiometer device.
|
Neuroimaging & Sensory Testing
Subjects from the Medical and Surgical Cohorts who agree to additional testing in the form of neuroimaging (via fMRI) and multimodal sensory testing. This group will undergo MRI, pain and auditory sensitivity testing. |
One time MRI scanning session examining brain structure and function in a resting state and after water consumption.
Other Names:
Pressure pain thresholds will be assess using computer-controlled pressures delivered by a device called the Multimodal Automated Sensory Testing System (MAST) device on to the subjects thumbnail bed.
Other Names:
Subjects' sensitivity to sound will be evaluated using a series of sounds delivered by a standard audiometer device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinically relevant subgroups of patients with lower urinary tract symptoms
Time Frame: Baseline
|
Identification of patient clusters based on their symptoms, clinical assessments, and/or other characteristics.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in lower urinary tract symptoms
Time Frame: baseline, 3 months, and 12 months
|
baseline, 3 months, and 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Kevin P Weinfurt, PhD, Duke University
- Study Chair: Claire Yang, MD, University of Washington
- Principal Investigator: Robert M Merion, MD, FACS, Arbor Research Collaborative for Health - DCC
Publications and helpful links
General Publications
- Coyne KS, Matza LS, Kopp ZS, Thompson C, Henry D, Irwin DE, Artibani W, Herschorn S, Milsom I. Examining lower urinary tract symptom constellations using cluster analysis. BJU Int. 2008 May;101(10):1267-73. doi: 10.1111/j.1464-410X.2008.07598.x. Epub 2008 Mar 11.
- Coyne KS, Barsdorf AI, Thompson C, Ireland A, Milsom I, Chapple C, Kopp ZS, Bavendam T. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS). Neurourol Urodyn. 2012 Apr;31(4):448-54. doi: 10.1002/nau.21202. Epub 2012 Mar 6.
- Bower WF, Yip SK, Yeung CK. Dysfunctional elimination symptoms in childhood and adulthood. J Urol. 2005 Oct;174(4 Pt 2):1623-7; discussion 1627-8. doi: 10.1097/01.ju.0000176599.91836.12. Erratum In: J Urol. 2005 Dec;174(6):2428.
- Harte SE, Wiseman J, Wang Y, Smith AR, Yang CC, Helmuth M, Kreder K, Kruger GH, Gillespie BW, Amundsen C, Kirkali Z, Lai HH; LURN Study Group. Experimental Pain and Auditory Sensitivity in Overactive Bladder Syndrome: A Symptoms of the Lower Urinary Tract Dysfunction Research Network (LURN) Study. J Urol. 2022 Jan;207(1):161-171. doi: 10.1097/JU.0000000000002147. Epub 2022 Aug 25.
- Helmuth ME, Smith AR, Andreev VP, Liu G; LURN Study Group, Lai HH, Cameron AP, Siddiqui NY. Use of Euclidean length to measure urinary incontinence severity based on the lower urinary tract symptoms tool. Am J Obstet Gynecol. 2018 Mar;218(3):357-359. doi: 10.1016/j.ajog.2017.12.219. Epub 2017 Dec 26. No abstract available.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LURN Phenotyping Study V8.0
- U01DK100017 (U.S. NIH Grant/Contract)
- U01DK100011 (U.S. NIH Grant/Contract)
- U01DK099932 (U.S. NIH Grant/Contract)
- U01DK099879 (U.S. NIH Grant/Contract)
- U01DK097780 (U.S. NIH Grant/Contract)
- U01DK097779 (U.S. NIH Grant/Contract)
- U01DK097776 (U.S. NIH Grant/Contract)
- U01DK097772 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Urinary Tract Symptoms
-
The Royal College of Surgeons of EnglandUniversity College, LondonCompletedUncomplicated Lower Urinary Tract Symptoms
-
National Taiwan University HospitalUnknownDisorder of the Lower Urinary TractTaiwan
-
ProVerum MedicalNot yet recruitingBPH With Symptomatic Lower Urinary Tract Symptoms
-
The University of Texas Medical Branch, GalvestonCompletedLower Urinary Tract Symptoms | Lower Gastrointestinal Tract Symptoms
-
Far Eastern Memorial HospitalCompletedPsychiatric Aspects in Women With Lower Urinary Tract SymptomsTaiwan
-
Baylor Research InstituteForte MedicalCompletedLower Urinary Tract Symptoms | Lower Urinary Tract InfectionUnited States
-
Jagiellonian UniversityPiotr ChlostaCompletedTo Evaluate Lower Urinary Tract Symptoms (LUTS) in PolandPoland
-
Boston Scientific CorporationTerminatedBPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States, Australia
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterUnknownPain | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States
-
San Carlo di Nancy HospitalLampugnani Farmaceutici S.p.A. (Nerviano, Milan, Italy)CompletedBPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsItaly
Clinical Trials on None-observational
-
American Gastroenterological AssociationUniversity of Pennsylvania; University of California, San Diego; University of... and other collaboratorsRecruitingClostridium Difficile Infection | Gut Microbiome | Fecal Microbiota TransplantationUnited States, Canada
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingCoagulation Disorder | Endocarditis | Valve Disease, HeartNetherlands
-
Eunice Kennedy Shriver National Institute of Child...New York State Department of Health; University at AlbanyCompletedObesity | Asthma | Blood Pressure | Developmental Delay | Allergies | Motor Delay
-
Taysha Gene Therapies, Inc.Withdrawn
-
University of BristolMedical Research Council; Wellcome Trust; Bristol Biomedical Research UnitCompletedPregnancy Related | Dietary Habits | Lead Poisoning
-
Laniado HospitalUnknownTO FIND THE CORRELATION BETWEEN TINS SCORE OUTCOMEIsrael
-
Vanderbilt University Medical CenterMassachusetts General Hospital; Mayo Clinic; University of British Columbia; University... and other collaboratorsRecruitingUrinary Tract Infections | Kidney StoneUnited States, Canada
-
Hugo W. Moser Research Institute at Kennedy Krieger...Recruiting
-
Central Hospital, Nancy, FranceUnknown
-
University of BristolMedical Research Council; Wellcome Trust; NestléCompletedFeeding and Eating Disorders of Childhood | Parent-Child Relations | Parenting | Child Behavior | Eating Behavior | Child Rearing